4D Molecular Therapeutics, Inc.
USD12.88
+1.28 (+11.03%)
CEO
David H. Kirn
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.68
Prev. Close
$11.60
Day Low
$11.68
Day High
$13.33
52W Low
$3.68
52W High
$13.33
Market Cap
$0.67B
Volume
1.48M
| 9,810 |
| $12.00 |
| 25 Jun 2026 | Bizily Scott | Chief Legal Officer | M-Exempt | Disposed | 9,810 | $4.14 |
| 23 Jun 2026 | Kirn David | director, officer: See Remarks | S-Sale | Disposed | 114,746 | $10.47 |
| 18 Jun 2026 | Tomasello Shawn | director | A-Award | Acquired | 50,000 | $9.42 |
| 18 Jun 2026 | THEUER CHARLES | director | A-Award | Acquired | 50,000 | $9.42 |
| 18 Jun 2026 | Miller-Rich Nancy | director | A-Award | Acquired | 50,000 | $9.42 |
| 18 Jun 2026 | GRAY SUSANNAH | director | A-Award | Acquired | 50,000 | $9.42 |
| 18 Jun 2026 | MILLIGAN JOHN F | director | A-Award | Acquired | 75,000 | $9.42 |
| 18 Jun 2026 | SBLENDORIO GLENN | director | A-Award | Acquired | 50,000 | $9.42 |